Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alphatec Holdings, Inc.ATEC · Entity 4720 | Director | June 10, 2026 | June 12, 2026 |
| Orthofix Medical Inc.OFIX · Entity 1975 | Director · President & CEO | February 28, 2023 | March 02, 2023 |
| REGENTIS BIOMATERIALS LTD.RGNT · Entity 7824 | Director | July 09, 2026 | July 13, 2026 |
| SI-BONE, Inc.SIBN · Entity 2501 | Director | June 09, 2023 | June 13, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alphatec Holdings, Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 264,283 |
Reported balance
After 2026-06-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 32,012 · Balance 264,283 F1: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.
Orthofix Medical Inc.
Report date February 28, 2023 · Filed March 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 377,741 |
Reported balance
After 2023-02-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-02-28 · Tax withholding · Disposed 16,290 · Balance 377,741 F1: Includes 217,134 unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 217,134 unvested restricted stock units.
REGENTIS BIOMATERIALS LTD.
Report date July 09, 2026 · Filed July 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.16 · Expires 2036-05-28 | Direct | 24,826 |
Reported balance
After 2026-07-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-09 · Grant · Acquired 24,826 · Balance 24,826 F1: This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F2: This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026.
F2: This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029.
SI-BONE, Inc.
Report date June 09, 2023 · Filed June 13, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 57,209 |
Reported balance
After 2023-06-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-06-09 · Grant · Acquired 4,866 · Balance 57,209 F1: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2: Includes 4,866 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date.
F2: Includes 4,866 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SeaSpine Holdings Corp
Report date January 05, 2023 · Filed January 10, 2023
Section 16 reporting ended · disclosed 2023-01-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 1
1 source rowRow 1 · 2023-01-05 · Disposition to issuer · Disposed 333,797 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 138,959 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-01-05 · Disposition to issuer · Disposed 52,392 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F4: These restricted stock units were assumed by Orthofix in the merger and replaced by 21,810 Orthofix restricted stock units. F3: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-01-05 · Disposition to issuer · Disposed 236,779 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F6: These restricted stock units were assumed by Orthofix in the merger and replaced by 98,571 Orthofix restricted stock units. F5: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.68 · Expires 2023-08-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-01-05 · Disposition to issuer · Disposed 325,000 · Balance 0 F8: This option was assumed by Orthofix in the merger and replaced with an option to purchase 135,297 shares of Orthofix at a price of $37.67 per share. F7: The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.19 · Expires 2024-01-27 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-01-05 · Disposition to issuer · Disposed 149,074 · Balance 0 F10: This option was assumed by Orthofix in the merger and replaced with an option to purchase 62,059 shares of Orthofix at a price of $34.09 per share. F9: The option vests as to 6.25% on June 1, 2016, 6.25% on June 30, 2016 and the remaining 87.5% in fourteen equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.24 · Expires 2027-01-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-01-05 · Disposition to issuer · Disposed 77,881 · Balance 0 F12: This option was assumed by Orthofix in the merger and replaced with an option to purchase 32,421 shares of Orthofix at a price of $43.82 per share. F11: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.01 · Expires 2028-01-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-01-05 · Disposition to issuer · Disposed 121,830 · Balance 0 F14: This option was assumed by Orthofix in the merger and replaced with an option to purchase 50,717 shares of Orthofix at a price of $28.85 per share. F13: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.93 · Expires 2028-04-23 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-01-05 · Disposition to issuer · Disposed 8,871 · Balance 0 F16: This option was assumed by Orthofix in the merger and replaced with an option to purchase 3,692 shares of Orthofix at a price of $23.86 per share. F15: The option fully vested and became exercisable on June 21, 2020. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.86 · Expires 2029-01-28 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-01-05 · Disposition to issuer · Disposed 261,699 · Balance 0 F18: This option was assumed by Orthofix in the merger and replaced with an option to purchase 108,945 shares of Orthofix at a price of $40.50 per share. F17: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.00 · Expires 2030-02-28 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2023-01-05 · Disposition to issuer · Disposed 31,866 · Balance 0 F20: This option was assumed by Orthofix in the merger and replaced with an option to purchase 13,265 shares of Orthofix at a price of $36.04 per share. F19: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 138,959 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock.
F3: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
F4: These restricted stock units were assumed by Orthofix in the merger and replaced by 21,810 Orthofix restricted stock units.
F5: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
F6: These restricted stock units were assumed by Orthofix in the merger and replaced by 98,571 Orthofix restricted stock units.
F7: The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F8: This option was assumed by Orthofix in the merger and replaced with an option to purchase 135,297 shares of Orthofix at a price of $37.67 per share.
F9: The option vests as to 6.25% on June 1, 2016, 6.25% on June 30, 2016 and the remaining 87.5% in fourteen equal quarterly installments thereafter.
F10: This option was assumed by Orthofix in the merger and replaced with an option to purchase 62,059 shares of Orthofix at a price of $34.09 per share.
F11: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F12: This option was assumed by Orthofix in the merger and replaced with an option to purchase 32,421 shares of Orthofix at a price of $43.82 per share.
F13: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F14: This option was assumed by Orthofix in the merger and replaced with an option to purchase 50,717 shares of Orthofix at a price of $28.85 per share.
F15: The option fully vested and became exercisable on June 21, 2020.
F16: This option was assumed by Orthofix in the merger and replaced with an option to purchase 3,692 shares of Orthofix at a price of $23.86 per share.
F17: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F18: This option was assumed by Orthofix in the merger and replaced with an option to purchase 108,945 shares of Orthofix at a price of $40.50 per share.
F19: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F20: This option was assumed by Orthofix in the merger and replaced with an option to purchase 13,265 shares of Orthofix at a price of $36.04 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 09, 2026 Filed Jul 13, 2026 21:06 UTC | REGENTIS BIOMATERIALS LTD. RGNT · Entity 7824 | GrantEmployee Stock Option (Right to Buy) · Derivative | 24,826 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001213900-26-077634 · ownership.xml · derivative · entry 1 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,826 Underlying: Ordinary Shares · 24,826 shares Expires 2036-05-28 F1 · security: This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F2 · security: This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 32,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001289408-26-000004 · form4-06122026_050608.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,283 F1 · security: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| May 11, 2026 Filed May 11, 2026 23:00 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 35,000 | $7.00 | $245,000.00 |
DisclosureSEC source: 0001289408-26-000002 · form4-05112026_070501.xml · nonDerivative · entry 3 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,271 Read SEC document |
| May 08, 2026 Filed May 11, 2026 23:00 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 43,847 | $7.54 | $330,606.38 |
DisclosureSEC source: 0001289408-26-000002 · form4-05112026_070501.xml · nonDerivative · entry 2 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,271 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.52 to $7.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 07, 2026 Filed May 11, 2026 23:00 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 56,153 | $7.49 | $420,585.97 |
DisclosureSEC source: 0001289408-26-000002 · form4-05112026_070501.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,424 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.48 to $7.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 21:30 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 15,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017266 · form4-06132025_050611.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,271 F1 · security: On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 11, 2025, issuer granted to the reporting person 15,131 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| August 02, 2024 Filed Aug 5, 2024 18:48 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Stock | 39,000 | $6.55 | $255,450.00 |
DisclosureSEC source: 0001415889-24-020722 · form4-08052024_060816.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,140 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.43 to $6.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:50 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 28,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-020473 · form4-07312024_100715.xml · nonDerivative · entry 2 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,140 F2 · security: Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. F3 · security: On July 29, 2024, issuer also granted to the reporting person 28,063 restricted stock units which vest in three equal installments on each of July 29, 2025, July 29, 2026, and July 29, 2027, conditioned upon continued board service. F3 · shares: On July 29, 2024, issuer also granted to the reporting person 28,063 restricted stock units which vest in three equal installments on each of July 29, 2025, July 29, 2026, and July 29, 2027, conditioned upon continued board service. F3 · balance_after: On July 29, 2024, issuer also granted to the reporting person 28,063 restricted stock units which vest in three equal installments on each of July 29, 2025, July 29, 2026, and July 29, 2027, conditioned upon continued board service. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 22:50 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 15,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-020473 · form4-07312024_100715.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,077 F1 · security: On July 29, 2024, issuer granted to the reporting person 15,077 restricted stock units which vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F2 · security: Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. F1 · shares: On July 29, 2024, issuer granted to the reporting person 15,077 restricted stock units which vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On July 29, 2024, issuer granted to the reporting person 15,077 restricted stock units which vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 20:31 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 4,866 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005114 · primarydocument.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,209 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 4,866 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:30 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 16,290 | $20.60 | $335,574.00 |
DisclosureSEC source: 0001209191-23-014687 · doc4.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,741 F1 · balance_after: Includes 217,134 unvested restricted stock units. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 23:56 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 5,824 | $21.22 | $123,585.28 |
DisclosureSEC source: 0001209191-23-006009 · doc4.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,031 F1 · balance_after: Includes 249,991 unvested restricted stock units. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 23:50 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantEmployee Stock Option (Right to Buy) · Derivative | 338,264 | $0.00 Strike: $20.90 | $0.00 |
DisclosureSEC source: 0001209191-23-002642 · doc4.xml · derivative · entry 2 Valentine Keith · CIK 0001289408 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,264 Underlying: Common Stock · 338,264 shares Expires 2033-01-05 F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 23:50 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 140,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002642 · doc4.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,855 F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. F2 · balance_after: Includes 260,896 unvested restricted stock units. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 31,866 | Not disclosed Strike: $15.00 | Not disclosed |
DisclosureSEC source: 0001637761-23-000031 · wf-form4_167330975155225.xml · derivative · entry 10 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,866 shares Expires 2030-02-28 F20 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 13,265 shares of Orthofix at a price of $36.04 per share. F19 · derivative.exercise_date: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 261,699 | Not disclosed Strike: $16.86 | Not disclosed |
DisclosureSEC source: 0001637761-23-000031 · wf-form4_167330975155225.xml · derivative · entry 9 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 261,699 shares Expires 2029-01-28 F18 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 108,945 shares of Orthofix at a price of $40.50 per share. F17 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 8,871 | Not disclosed Strike: $9.93 | Not disclosed |
DisclosureSEC source: 0001637761-23-000031 · wf-form4_167330975155225.xml · derivative · entry 8 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,871 shares Expires 2028-04-23 F16 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 3,692 shares of Orthofix at a price of $23.86 per share. F15 · derivative.exercise_date: The option fully vested and became exercisable on June 21, 2020. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 121,830 | Not disclosed Strike: $12.01 | Not disclosed |
DisclosureSEC source: 0001637761-23-000031 · wf-form4_167330975155225.xml · derivative · entry 7 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 121,830 shares Expires 2028-01-01 F14 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 50,717 shares of Orthofix at a price of $28.85 per share. F13 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 77,881 | Not disclosed Strike: $18.24 | Not disclosed |
DisclosureSEC source: 0001637761-23-000031 · wf-form4_167330975155225.xml · derivative · entry 6 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 77,881 shares Expires 2027-01-01 F12 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 32,421 shares of Orthofix at a price of $43.82 per share. F11 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 149,074 | Not disclosed Strike: $14.19 | Not disclosed |
DisclosureSEC source: 0001637761-23-000031 · wf-form4_167330975155225.xml · derivative · entry 5 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 149,074 shares Expires 2024-01-27 F10 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 62,059 shares of Orthofix at a price of $34.09 per share. F9 · derivative.exercise_date: The option vests as to 6.25% on June 1, 2016, 6.25% on June 30, 2016 and the remaining 87.5% in fourteen equal quarterly installments thereafter. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 325,000 | Not disclosed Strike: $15.68 | Not disclosed |
DisclosureSEC source: 0001637761-23-000031 · wf-form4_167330975155225.xml · derivative · entry 4 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 325,000 shares Expires 2023-08-01 F8 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 135,297 shares of Orthofix at a price of $37.67 per share. F7 · derivative.exercise_date: The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerRestricted Stock Units · Derivative | 236,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-23-000031 · wf-form4_167330975155225.xml · derivative · entry 3 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 236,779 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F6 · price: These restricted stock units were assumed by Orthofix in the merger and replaced by 98,571 Orthofix restricted stock units. F5 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. F5 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerRestricted Stock Units · Derivative | 52,392 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-23-000031 · wf-form4_167330975155225.xml · derivative · entry 2 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,392 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F4 · price: These restricted stock units were assumed by Orthofix in the merger and replaced by 21,810 Orthofix restricted stock units. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerCommon Stock | 333,797 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-23-000031 · wf-form4_167330975155225.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 138,959 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 22:22 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 12,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-23-000008 · wf-form4_167278453877800.xml · derivative · entry 3 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,183 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The reporting person was granted 36,549 restricted stock units on January 1, 2020, which vested in three equal installments on each of January 1, 2021, 2022, and 2023. F3 · derivative.expiration_date: The reporting person was granted 36,549 restricted stock units on January 1, 2020, which vested in three equal installments on each of January 1, 2021, 2022, and 2023. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 22:22 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 7,170 | $8.35 | $59,869.50 |
DisclosureSEC source: 0001637761-23-000008 · wf-form4_167278453877800.xml · nonDerivative · entry 2 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,797 F2 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2023. No shares were sold in connection with this transaction. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 22:22 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 12,183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-23-000008 · wf-form4_167278453877800.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 21:07 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 2,385 | $4.80 | $11,448.00 |
DisclosureSEC source: 0001637761-22-000107 · wf-form4_165670960952232.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,784 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 20:04 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 8,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005235 · primarydocument.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,343 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 8,324 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 01:37 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantEmployee Stock Option (Right to Buy) · Derivative | 31,866 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001637761-22-000042 · wf-form4_164627140780449.xml · derivative · entry 2 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,866 Underlying: Common Stock · 31,866 shares Expires 2030-02-28 F3 · derivative.exercise_date: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 01:37 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 236,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-22-000042 · wf-form4_164627140780449.xml · derivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,779 Underlying: Common Stock · 236,779 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. Read SEC document |
| January 28, 2022 Filed Feb 2, 2022 00:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 26,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-22-000025 · wf-form4_164376097081881.xml · derivative · entry 3 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,392 Underlying: Common Stock · 26,196 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The reporting person was granted 78,588 restricted stock units on January 28, 2021, which vest in three equal installments on each of January 28, 2022, 2023, and 2024. F3 · derivative.expiration_date: The reporting person was granted 78,588 restricted stock units on January 28, 2021, which vest in three equal installments on each of January 28, 2022, 2023, and 2024. Read SEC document |
| January 28, 2022 Filed Feb 2, 2022 00:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 13,798 | $11.39 | $157,159.22 |
DisclosureSEC source: 0001637761-22-000025 · wf-form4_164376097081881.xml · nonDerivative · entry 2 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,399 F2 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 28, 2022. No shares were sold in connection with this transaction. Read SEC document |
| January 28, 2022 Filed Feb 2, 2022 00:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 26,196 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-22-000025 · wf-form4_164376097081881.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 02:20 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 12,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-22-000007 · wf-form4_164134920472150.xml · derivative · entry 6 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,183 Underlying: Common Stock · 12,183 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F6 · derivative.exercise_date: The reporting person was granted 36,549 restricted stock units on January 1, 2020, which vest in three equal installments on each of January 1, 2021, 2022, and 2023. F6 · derivative.expiration_date: The reporting person was granted 36,549 restricted stock units on January 1, 2020, which vest in three equal installments on each of January 1, 2021, 2022, and 2023. Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 02:20 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 7,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-22-000007 · wf-form4_164134920472150.xml · derivative · entry 5 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,789 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: The reporting person was granted 23,365 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. F5 · derivative.expiration_date: The reporting person was granted 23,365 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 02:20 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 11,167 | $13.62 | $152,094.54 |
DisclosureSEC source: 0001637761-22-000007 · wf-form4_164134920472150.xml · nonDerivative · entry 4 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,001 F4 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2022. No shares were sold in connection with this transaction. Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 02:20 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 12,183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-22-000007 · wf-form4_164134920472150.xml · nonDerivative · entry 3 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 02:20 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 7,789 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-22-000007 · wf-form4_164134920472150.xml · nonDerivative · entry 2 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| December 31, 2021 Filed Jan 5, 2022 02:20 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 1,026 | $8.92 | $9,151.92 |
DisclosureSEC source: 0001637761-22-000007 · wf-form4_164134920472150.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,196 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2020. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 23:07 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 1,356 | $8.92 | $12,095.52 |
DisclosureSEC source: 0001637761-21-000151 · wf-form4_162526726060179.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,170 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2020. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:41 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 3,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004256 · primarydocument.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,019 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 3,848 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 28, 2021 Filed Jan 29, 2021 22:27 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantEmployee Stock Option (Right to Buy) · Derivative | 261,699 | $0.00 Strike: $16.86 | $0.00 |
DisclosureSEC source: 0001637761-21-000031 · wf-form4_161195921703720.xml · derivative · entry 2 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,699 Underlying: Common Stock · 261,699 shares Expires 2029-01-28 F3 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document |
| January 28, 2021 Filed Jan 29, 2021 22:27 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 78,588 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-21-000031 · wf-form4_161195921703720.xml · derivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,588 Underlying: Common Stock · 78,588 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:13 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 12,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-21-000015 · wf-form4_160988120481159.xml · derivative · entry 8 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,366 Underlying: Common Stock · 12,183 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F7 · derivative.exercise_date: The reporting person was granted 36,549 restricted stock units on January 1, 2020, which vest in three equal installments on each of January 1, 2021, 2022, and 2023. F7 · derivative.expiration_date: The reporting person was granted 36,549 restricted stock units on January 1, 2020, which vest in three equal installments on each of January 1, 2021, 2022, and 2023. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:13 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 7,788 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-21-000015 · wf-form4_160988120481159.xml · derivative · entry 7 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,789 Underlying: Common Stock · 7,788 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F6 · derivative.exercise_date: The reporting person was granted 23,365 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. F6 · derivative.expiration_date: The reporting person was granted 23,365 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:13 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 27,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-21-000015 · wf-form4_160988120481159.xml · derivative · entry 6 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,428 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: The reporting person was granted 82,284 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020 and 2021. F5 · derivative.expiration_date: The reporting person was granted 82,284 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020 and 2021. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:13 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 25,450 | $17.45 | $444,102.50 |
DisclosureSEC source: 0001637761-21-000015 · wf-form4_160988120481159.xml · nonDerivative · entry 5 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,814 F4 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2021. No shares were sold in connection with this transaction. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:13 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 12,183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-21-000015 · wf-form4_160988120481159.xml · nonDerivative · entry 4 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:13 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 7,788 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-21-000015 · wf-form4_160988120481159.xml · nonDerivative · entry 3 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.